Abstract: The invention relates to macrocyclic lactam derivatives of formula I ##STR1## wherein R is hydrogen or acyl; m is an integer from 4 to 9 inclusive; n is 1 or 2; p is zero, 1 or 2; X is --CONH-- or --NHCO--; Y is S, O or CH.sub.2 ; R.sub.1 is --COOH; or R.sub.1 is ##STR2## in which R.sub.2 is hydrogen, lower alkyl, aryl-lower alkyl, amino-lower alkyl, hydroxy-lower alkyl, acyloxy-lower alkyl, lower alkoxy-lower alkyl, mercapto-lower alkyl, lower alkyl-(thio, sulfinyl or sulfonyl)-lower alkyl, or carboxy-lower alkyl, R.sub.3 is hydrogen or lower alkyl, and q is zero or an integer from 1 to 5 inclusive; or R.sub.1 is ##STR3## in which R.sub.4 is hydrogen, lower alkyl, lower alkoxy, hydroxy or acyloxy, and r is 1 or 2; or R.sub.1 is ##STR4## in which s is 1 or 2; or R.sub.1 is ##STR5## in which R.sub.5 and R.sub.6 independently represent hydrogen, lower alkyl, C.sub.5 - or C.sub.
Type:
Grant
Filed:
November 26, 1991
Date of Patent:
September 14, 1993
Assignee:
Ciba-Geigy Corporation
Inventors:
Lawrence J. MacPherson, James L. Stanton
Abstract: There are provided alkyl esters of 5-heterocyclic-pyridine-2,3-dicarboxylic acids useful as intermediates for the preparation of highly effective 5-heterocyclic-2-(2-imidazolin-2-yl)pyridine herbicidal agents and methods for the preparation thereof.
Abstract: Compounds of the formula: ##STR1## where R is hydrogen, C.sub.1 -C.sub.10 alkylcarbonyl, or C.sub.1 -C.sub.10 alkyl which can be substituted by amino or cyano, R.sup.1 and R.sup.2 are independently hydrogen, hydroxyl or amino, and the pharmaceutically aceptable salts and esters thereof. Pharmaceutical compositions and methods of their use are also provided for.
Abstract: Disclosed is a two-step method for the preparation of cyclic urea products which comprises: heating a diamine with urea in a mole ratio of about 1 at a temperature from about 120.degree. C. to 140.degree. C. until a mole of ammonia is liberated and slowly heating the intermediate with an alcohol or polyether solvent to a temperature from about 160.degree. C. to 200.degree. C. to produce the cyclic urea products.
Abstract: Lactams of the general structural formula: ##STR1## wherein R is hydrogen or C.sub.1-10 alkyl. These compounds are macrolides useful as antibiotics and as intermediates for the synthesis of other macrolide antibiotics.
Abstract: Compounds of the formula ##STR1## are disclosed. These compounds inhibit the angiotensinogen-cleaving action of the natural proteolytic enzyme, renin, are useful in treating, preventing or managing renin-associated hypertension, hyperaldosteronism, congestive heart failure, and glaucoma.
Type:
Grant
Filed:
June 11, 1991
Date of Patent:
March 16, 1993
Assignee:
Merck & Co., Inc.
Inventors:
William J. Greenlee, Ralph A. Rivero, Ann E. Weber, Lihu Yang
Abstract: This invention relates to cyclic sulfur-containing compounds of the formula [I] and salts thereof which are useful for immunomodulator and treatment of liver diseases.
Abstract: Linear or multidimensional, crosslinking, solvent resistant oxazole, thiazole, or imidazole (i.e., heterocycle) oligomers and blends of the crosslinking oligomers and noncrosslinking comparable polymers are described. The oligomers are prepared by reacting tetraamines, diaminodiols, or diaminothiols (i.e. four-functional compounds) with poly-carboxylic acid halides, and crosslinking phenylimide end cap monomers in a suitable solvent under an inert atmosphere.
Abstract: Non-peptidyl compounds characterized generally as .beta.-aminoacyl aminodiol carbamates are useful as renin inhibitors for the treatment of hypertension.
Abstract: Mercaptoacyl aminolactam inhibitors of endopeptidases of the formula ##STR1## wherein Y is -(CHR.sup.5).sub.n (CR.sup.3 R.sup.4)- or -(CR.sup.3 R.sup.4).sub.p X(CR.sup.3 R.sup.4).sub.q -,wherein two substituents selected from the group consisting of R.sup.3, R.sup.4 and R.sup.5, can form a benzene, cyclopentane or cyclohexane ring;X is -O-, -S-, -SO- or -SO.sub.2 -;Q is hydrogen or R.sup.6 CO-;m is 1 or 2;n is 1, 2, 3 or 4;p is 1 or 2;q is 2 or 3;R.sup.1 is lower alkyl, aryl or heteroaryl;R.sup.2 is hydrogen, lower alkyl, hydroxylower alkyl, lower alkoxylower alkyl, aryllower alkyl or heteroaryllower alkyl;R.sup.3 and R.sup.4 are independently hydrogen, lower alkyl, aryllower alkyl or heteroaryllower alkyl;R.sup.5 is hydrogen, lower alkyl, aryllower alkyl, heteroaryllower alkyl, hydroxy, lower alkoxy, mercapto, or lower alkylthio; and R.sup.
Abstract: A lubricant/fuel additive which is the reaction product of polyoxyalkylene dicarboxylic acids and hydrocarbyl-substituted mono- and bis-succinimides of polyamines.
Abstract: Cyclic sulfur-containing compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are the same or different and each is hydrogen or lower alkyl,R.sup.3 is hydrogen or lower alkyl,X is S--S,m is 0 or 1 andn is 1 or 2, with the proviso that when m is 0,n is 2, and pharmaceutically acceptable salts thereof.Such compounds are useful for treating liver disorders and autoimmune diseases.
Abstract: Hydrazide functionalized 2-hydroxybenzophenone ultraviolet light and heat stabilizers and derivatives are disclosed having the general formula: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, X, Y, Z, all substituents thereof, and n are set forth in the Summary of the Invention. Y--N(R.sup.6)--Z is the hydrazide or derivative group and --X--R.sup.5 -- links the hydrazide group to an aromatic nucleus of the optionally substituted benzophenone group. Derivatives are, for example, acyl hydrazides, diacyl hydrazides (including imides), hydrazones and alkyl hydrazides. The compounds are useful as ultraviolet light absorbers and heat stabilizers for plastics.
Abstract: The present invention relates to compounds of the formula ##STR1## wherein R.sub.c is carboxy, esterified carboxy or amidated carboxy;R.sub.2 is hydrogen or lower alkyl or joins with R.sub.a and R.sub.b and the atoms therebetween to form a fused ring ##STR2## and either R.sub.a is methyl and R.sub.b is ##STR3## or R.sub.2 and R.sub.b and the atoms therebetween form a group wherein R.sub.3 and R.sub.4 are either both hydrogen, or together are propylene, butylene, or with the two atoms to which they are attached form a benzene ring. Methods of manufacture and use thereof in the production of angiotensin converting enzyme inhibitors are disclosed.
Abstract: Novel cyclic ester-amides having the formula: ##STR1## where R is an alkyl group having from 2 to 5 carbon atoms, and x ranges from 2 to 6 by reacting a polyethylene glycol monoamine having the formula NH.sub.2 --(CH.sub.2 CH.sub.2 O).sub.x --H, where x is as above, with at least one dicarboxylic acid, where the dicarboxylic acid is selected from the group consisting of glutaric, adipic, pimelic acids and mixtures thereof. The a molar ratio of polyethylene glycol monoamine to dicarboxylic acid should be about 1:1. Catalysts may be optionally used, and may include such compounds as titanium alkoxides; and zinc, manganese and antimony salts of carboxylic acids. This method is anticipated to be a useful step in a new preparation of valuable cyclic products.
Abstract: A novel dioxa-diazacyclohexadecenetetrone isolated from the fermentation of a cyanobacterium (Nostoc sp.) is described. The compound is a new antifungal agent with a specificity generally toward filamentous fungi but also effective against Cryptococcus sp.
Type:
Grant
Filed:
July 15, 1988
Date of Patent:
August 7, 1990
Assignee:
Merck & Co., Inc.
Inventors:
Charles F. Hirsch, Jerrold M. Liesch, Michael J. Salvatore, Robert E. Schwartz, David F. Sesin
Abstract: The present invention relates to compounds of the formula ##STR1## wherein R.sub.c is carboxy, esterified carboxy or amidated carboxy; R.sub.2 is hydrogen or lower alkyl or joins with R.sub.a and R.sub.b and the atoms therebetween to form a fused ring ##STR2## and either R.sub.a is methyl and R.sub.b is ##STR3## or R.sub.2 and R.sub.b and the atoms therebetween form a group ##STR4## wherein R.sub.3 and R.sub.4 are either both hydrogen, or together are propylene, butylene, or with the two atoms to which they are attached form a benzene ring. Methods of manufacture and use thereof in the production of angiotensin converting enzyme inhibitors are disclosed.
Abstract: A process is disclosed for synthesizing large quantities of a compound of formula I ##STR1## wherein a solution of a compound of formula II ##STR2## is mixed with a solution of a compound of formula III ##STR3## under suitable process conditions, and wherein A, same or different, is N--R, O, S, CRR' or P(O)R, and R and R' are hydrogen, alkyl, alkylidene, aryl, tosyl, allyl or benzyl, and B is O.Compounds of formula I may be reduced to form an azacorand of formula IV ##STR4## wherein K and L, same or different, are N--R, O, S, CRR', or P(O)R, and R and R' are hydrogen, alkyl, alkylidene, aryl, tosyl, allyl or benzyl.Also disclosed in a compound of formula IV synthesized in accordance with the above procedure wherein K and L are not both O or S.
Abstract: 4-[(.alpha.,.alpha.-Diaryl)-hydroxymethyl]-1-piperidinylalkylcyclic carbamate derivatives having the formula: ##STR1## wherein; R is hydrogen, loweralkyl, cycloalkyl, phenyl and substituted phenyl;Ar and Ar.sup.1 are phenyl, substituted phenyl or pyridinyl;alk is a straight or branched hydrocarbon chain;R.sup.1 is loweralkyl substituted for hydrogen on a ring carbon.The compounds are useful antihistamines and in controlling allergic response.
Abstract: A novel semi-synthetic compound, 10-[(3-chloro-4-methyoxyphenyl)methyl]-16-(2,3-dihydroxy-1-methyl-3-phenyl propyl)-6-methyl-3-(2-methylpropyl)-1,4- dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone which has potential as a treating agent for mycotic infections is described.
Abstract: A novel semi-synthetic compound, 10-[(3-chloro-4-methoxyphenylmethyl]-6-methyl-3-(2-methylpropyl)-16-(1-met hyl-3-phenyl-2-propenyl)-1,4-dioxa-8, 11-diazacyclohexadec-13-ene-2,5,9,12-tetrone, which has potential as a treating agent for mycotic infections is disclosed.
Abstract: Novel cystine compounds of the general formula I are proposed wherein the independently of one another each represent a, preferably natural, L-amino acid, in particular glycine, alanine, proline, threonine, serine, valine, arginine, lysine or ornithine; the R.sub.1 independently of one another each stand for an acyl group of an organic acid with 2 to 5 carbon atoms, preferably for acetyl-, propionyl-, succinyl- or hydroxysuccinyl- or for a, preferably natural, L-amino acid which via its carboxylic group is linked amide-like to the amino group of the amino acid AS, the amino acids indicated as preferred for AS also being preferred for the amino acids of R.sub.1, or the two R.sub.1 together form the acyl group of an organic dicarboxylic acid, preferably the succinic or malic group; and the R.sub.2 independently of one another each are an alkoxy group with 1 to 4 carbon atoms, preferably methoxy or ethoxy, the hydroxy group, where in case of the meaning of R.sub.
Type:
Grant
Filed:
November 2, 1987
Date of Patent:
January 31, 1989
Assignees:
Bleiberger Bergwerks Union, Pfrimmer & Co. Pharmazeutische Werke Erlangen GmbH & Co. KG
Inventors:
Naderer Rainer, Buxbaum Lothar, Langer Klaus
Abstract: An isoquinoline derivative represented by the formula (I) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and A are as defined in the disclosure, or a pharmacologically acceptable acid salt thereof. These compounds have an excellent relaxation action on blood vessels, particularly coronary arteries, and on bronchial tubes. Accordingly, the compounds can be advantageously utilized as drugs for prevention and treatment of angina, myocardial infarction, cardiovascular thrombosis, cerebrovascular thrombosis, hypertonia, asthma and other various circulatory and respiratory organ diseases.
Abstract: There are disclosed compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are each, independently, hydrogen or lower alkyl, or R.sup.1 and R.sup.2 taken together represent ##STR2## A is O or NR.sup.3 ; B is --(CH.sub.2).sub.n --, ##STR3## R.sup.3 is hydrogen or lower alkyl; R.sup.4 is hydrogen, lower alkyl, aryl of 6-12 carbon atoms or halo;R.sup.5 is unsubstituted or substituted phenyl, 2-pyridinyl, 2-pyrimidinyl, 2-pyrazinyl or 3-pyridazinyl, where the substituents are selected from the group lower alkyl, lower alkoxy, halo, cyano, nitro and trifluoromethyl;Z is --(CH.sub.2).sub.n -- or vinylene;X is lower alkylene, vinylene or O;m is 2-5;n is 1-3;o is 1-5;and the pharmaceutically acceptable salts thereof and their use as antipsychotic/anxiolytic agents having a low liability for extrapyramidal side effects.
Type:
Grant
Filed:
June 25, 1986
Date of Patent:
November 24, 1987
Assignee:
American Home Products Corporation
Inventors:
Magid A. Abou-Gharbia, Guy A. Schiehser
Abstract: There are disclosed a processing solution having bleaching ability for use in light-sensitive silver halide photographic material, which comprises at least one selected from metal complexes of large cyclic polyamine derivatives and a method for processing of light-sensitive silver halide photographic material, which comprises carrying out development processing of an exposed light-sensitive silver halide photographic material and then processing the developed material with the processing solution.The processing solution of the present invention has potent bleaching power, and can afford excellent photographic image characteristics by processing therewith.
Type:
Grant
Filed:
March 24, 1986
Date of Patent:
October 27, 1987
Assignee:
Konishiroku Photo Industry Co., Ltd.
Inventors:
M. Tanaka, Kazuhiro Kobayashi, Shigeharu Koboshi
Abstract: The present inveniton relates to novel lithium ionophores, to a process for producing such lithium ionophores and to their uses as pharmaceutical compositions, electrodes and as components of batteries.
Type:
Grant
Filed:
January 14, 1981
Date of Patent:
March 10, 1987
Assignee:
Yeda Research and Development Company Ltd.